• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 38 of 100
A researcher works on virus replication in order to develop a vaccine against the coronavirus COVID-19, in Belo Horizonte, state of Minas Gerais, Brazil, on March 26, 2020. - The Ministry of Health convened The Technological Vaccine Center of the Federal University of Minas Gerais laboratory to conduct research on the coronavirus COVID-19 in order to diagnose, test and develop a vaccine. (Photo by Douglas MAGNO / AFP) (Photo by DOUGLAS MAGNO/AFP via Getty Images)
Commentary
These pharmaceutical companies are the top inventors and innovators
By IDEA PharmaApril 6, 2020
Johnson & Johnson hopes to have its promising coronavirus vaccine approved by early 2021
Health
Johnson & Johnson hopes to have its promising coronavirus vaccine approved by early 2021
By Sy MukherjeeMarch 30, 2020
Coronavirus Glass Sculpture
Commentary
The coronavirus pandemic has shattered the status quo on drug development. We should build on that
By E. Richard GoldMarch 26, 2020
Moderna coronavirus vaccine
Newsletters
The first U.S. coronavirus vaccine trials have begun
By Sy MukherjeeMarch 17, 2020
President Trump Holds News Conference In The Rose Garden Of White House
Health
Walmart, Target, CVS, and Walgreens will loan space for coronavirus test centers
By Phil WahbaMarch 13, 2020
Gilead coronavirus trial
Newsletters
A coronavirus drug has already been deployed in the U.S. as the WHO declares a pandemic
By Sy MukherjeeMarch 11, 2020
Coronavirus drug Gilead Washington
Health
Gilead’s coronavirus treatment is already being used in Washington state
By Sy MukherjeeMarch 10, 2020
Gates Foundation Mastercard Wellcome coronavirus
Newsletters
A powerhouse trio pledges up to $125 million to fight coronavirus
By Sy MukherjeeMarch 10, 2020
Coronavirus Research Work
Health
Gates Foundation, Mastercard, and Wellcome team up to fuel coronavirus drug development
By Sy MukherjeeMarch 10, 2020
Testing for coronavirus should be free, but it’s not always that simple
Health
Testing for coronavirus should be free, but it’s not always that simple
By Sy MukherjeeMarch 3, 2020
Biogen Sangamo Alzheimers gene therapy
Newsletters
Biogen is doubling down on Alzheimer’s with a massive gene therapy deal
By Sy MukherjeeFebruary 28, 2020
Gilead coronavirus trial
Newsletters
Can Gilead tame the coronavirus?
By Sy MukherjeeFebruary 27, 2020
Gilead remdesivir clinical trials
Health
Gilead’s coronavirus treatment is barreling its way into new clinical trials
By Sy MukherjeeFebruary 26, 2020
COVID-19-Coronavirus-microscope
Health
The first U.S. trial for a coronavirus treatment has started
By Sy MukherjeeFebruary 25, 2020
Japan taps an unexpected drugmaker for its coronavirus treatment
Japan taps an unexpected drugmaker for its coronavirus treatment
By Naomi Xu ElegantFebruary 25, 2020
1...
  • 36
  • 37
  • 38
  • 39
  • 40
...100
Most Popular
Law
Egg companies made $1.22 billion in profit off a $6 carton — now they’re buying their way out of a price-fixing case with 53 million donated eggsplaceholder alt text
By Wyatte Grantham-Philips and The Associated PressJuly 2, 2026
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
Mark Zuckerberg feeds his cows macadamia nuts and beer to create the 'highest-quality beef in the world' on his $300 million estate in Hawaiiplaceholder alt text
By Sasha RogelbergJuly 2, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.